Literature DB >> 16148481

Increase in capillary perfusion following low-intensity ultrasound and microbubbles during postischemic reperfusion.

Silvia Bertuglia1.   

Abstract

OBJECTIVES: We postulated that the increase in shear stress caused by microbubbles in the presence of low-intensity ultrasound increases vasodilation in ischemia/reperfusion.
DESIGN: Prospective, randomized, and blinded experimental study.
SETTING: Research laboratory.
SUBJECTS: Forty hamsters were subjected to ischemia/reperfusion and observed by intravital microscopy.
INTERVENTIONS: Ultrasound (2.5 MHz, 1.3 mechanical index, 2.0 peak pressure) was applied to the hamster cheek pouch in ischemia/reperfusion with and without microbubbles (Levovist or Sono Vue) at baseline (15 mins) and at the beginning (15 mins) of reperfusion after ischemia (30 mins).
MEASUREMENTS AND MAIN RESULTS: Arterial diameter (A2-A3, 38.5 +/- 5.3 microm; A4,15.0 +/- 7.0 microm), red blood cell velocity, wall shear stress, permeability, perfused capillary length, and adherent leukocytes in venules were evaluated. Lipid peroxides were also determined in the systemic blood. Ultrasound and microbubbles in reperfusion significantly increased the diameter (A2-A3 Sono Vue, 33%; Levovist, 53% vs. ischemia/reperfusion, p < .05; A4, Sono Vue, 93%; Levovist, 104% vs. ischemia/reperfusion, p < .05), red blood cell velocity, flow, and shear stress in both A4 and A2-A3 arterioles. Shear stress was significantly higher with Levovist (A2-A3, 105%; A4, 185%) and Sono Vue (A2, 108%; A4, 140% vs. ischemia/reperfusion, p < .05) than ultrasound alone in arterioles. With ischemia/reperfusion, perfused capillary length was reduced significantly, whereas it increased with Levovist and Sono Vue (43%, 41% vs. ischemia/reperfusion p < .05). Lipid peroxides increased early during reperfusion and remained at increased levels throughout reperfusion. Lipid peroxides were unchanged after ultrasound alone or ultrasound with Sono Vue or Levovist during ischemia/reperfusion. With ultrasound there was a significant increase in vascular permeability vs. ischemia/reperfusion. Treatment with Sono Vue (-36%) and Levovist (-57%) decreased permeability vs. ischemia/reperfusion in reperfusion (p < .001). Ischemia/reperfusion had significantly increased leukocyte adhesion. Ultrasound alone (-39%) or with Sono Vue (-64%) and Levovist (-57%) caused smaller increases in leukocyte adhesion than ischemia/reperfusion (p < .05).
CONCLUSIONS: Ultrasound and microbubbles equilibrate microvascular shear stress, thus avoiding the failure of capillary perfusion in postischemic reperfusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148481     DOI: 10.1097/01.ccm.0000178356.90173.73

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Augmentation of limb perfusion and reversal of tissue ischemia produced by ultrasound-mediated microbubble cavitation.

Authors:  J Todd Belcik; Brian H Mott; Aris Xie; Yan Zhao; Sajeevani Kim; Nathan J Lindner; Azzdine Ammi; Joel M Linden; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2015-04       Impact factor: 7.792

2.  Flow Augmentation in the Myocardium by Ultrasound Cavitation of Microbubbles: Role of Shear-Mediated Purinergic Signaling.

Authors:  Federico Moccetti; Todd Belcik; Yllka Latifi; Aris Xie; Koya Ozawa; Eran Brown; Brian P Davidson; William Packwood; Azzdine Ammi; Sabine Huke; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2020-06-10       Impact factor: 5.251

3.  Ultrasonic microbubble VEGF gene delivery improves angiogenesis of senescent endothelial progenitor cells.

Authors:  Yi-Nan Lee; Yih-Jer Wu; Hsin-I Lee; Hsueh-Hsiao Wang; Chiung-Yin Chang; Ting-Yi Tien; Chao-Feng Lin; Cheng-Huang Su; Hung-I Yeh
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

4.  Diagnostic Ultrasound and Microbubbles Treatment Improves Outcomes of Coronary No-Reflow in Canine Models by Sonothrombolysis.

Authors:  Hairui Li; Yongkang Lu; Yili Sun; Gangbin Chen; Junfen Wang; Shifei Wang; Chixiong Huang; Lintao Zhong; Xiaoyun Si; Wangjun Liao; Yulin Liao; Shiping Cao; Jianping Bin
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.